Michael Visit 2 - Patient with diabetes complaining of leg pain, 3-month follow-up
| Title: | Michael Visit 2 - Patient with diabetes complaining of leg pain, 3-month follow-up |
| Topic: | Diabetology |
| Relevant Terms: | Diabetes, Diabetes Leg Pain, Endocrinology, Lower Extremity Pain, Neurology, Neuropathy, Painful Diabetic Neuropathy, Peripheral Diabetic Neuropathy, Peripheral Neuropathy |
| Primary Audience: | Primary care practitioners and other healthcare professionals who treat adults with diabetes and peripheral neuropathy including neurologists; podiatrists; and endocrinologists |
| Launch Date: | 14-Sep-09 |
| Credits: | 0.75 AMA PRA Category 1 Credit™ |
| Expiration Date: | 31-Dec-12 |
Learning Objectives
After completion of this activity, participants should be better able to:
- Evaluate the lower extremities of people with diabetes based on history and physical examination, focusing on estimation of underlying pathology and accurate quantification of pain to make a differential diagnosis
- Determine the need for, and identify specific types of, further evaluative testing for painful diabetic feet based on differential diagnosis
- Design effective preventive and treatment strategies for diabetic peripheral neuropathies, utilizing interventions specifically targeting functional preservation
- Initiate, manage, modify, and titrate medical therapies for diabetic peripheral neuropathies early in their natural history to optimize clinical impact
Faculty
Planning Committee:
Julie Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA
James Neighbours, MEd
Assistant Director, Education Technology Services
Professional Education
Joslin Diabetes Center
Boston, MA
DISCLOSURE POLICY STATEMENT
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.
COURSE VIEWING REQUIREMENTS
Release Date: September 14, 2009
Expiration Date: December 31, 2012
ACKNOWLEDGEMENT
This activity is sponsored by Joslin Diabetes Center.

This activity is supported by an educational grant from Pfizer Inc.
If you have any questions regarding this activity, send an email to profedweb@joslin.harvard.edu.
Copyright © 2011 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.
Julie Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA
James Neighbours, MEd
Assistant Director, Education Technology Services
Professional Education
Joslin Diabetes Center
Boston, MA
DISCLOSURE POLICY STATEMENT
As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of the Joslin Diabetes Center.
Dr. Beaser is on the academic advisory board for AstraZeneca/Bristol-Myers Squibb.
Dr. Freeman is a consultant for Avigen, Inc., Chelsea Pharmaceuticals International Ltd., Eli Lilly and Company, GlaxoSmithKline, Keryx Biopharmaceuticals, Inc., NeuroMetrix, Inc., Pfizer Inc, Solace Pharmaceuticals, and XTL Biopharmaceuticals Ltd., and is on the speakers bureau for Eli Lilly and Company and Pfizer Inc.
Dr. Giurini has no relevant financial relationships.
Ms. Brown has no relevant financial relationships.
Mr. Neighbours has no relevant financial relationships.
Dr. Freeman is a consultant for Avigen, Inc., Chelsea Pharmaceuticals International Ltd., Eli Lilly and Company, GlaxoSmithKline, Keryx Biopharmaceuticals, Inc., NeuroMetrix, Inc., Pfizer Inc, Solace Pharmaceuticals, and XTL Biopharmaceuticals Ltd., and is on the speakers bureau for Eli Lilly and Company and Pfizer Inc.
Dr. Giurini has no relevant financial relationships.
Ms. Brown has no relevant financial relationships.
Mr. Neighbours has no relevant financial relationships.
ACCREDITATION STATEMENT
The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION
Joslin Diabetes Center designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Joslin Diabetes Center designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
To Obtain CME Credits
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the posttest and activity evaluation.
- Physicians who successfully complete the posttest and evaluation will receive CME credit. You must score with a 60% or higher on the posttest to receive credit for this activity.
- All other participants who successfully complete the posttest and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
| PC Internet Explorer (v6 or greater), or Firefox |
MAC Safari |
Release Date: September 14, 2009
Expiration Date: December 31, 2012
ACKNOWLEDGEMENT
This activity is sponsored by Joslin Diabetes Center.
This activity is supported by an educational grant from Pfizer Inc.
If you have any questions regarding this activity, send an email to profedweb@joslin.harvard.edu.
Copyright © 2011 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.


